Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Search results for: 'p53 and mdm2 proteins interaction inhibitor chiral'

Items 1-10 of 34

Page
per page
  1. NVP-BEP800
    A4064 NVP-BEP800
    Target: HSP90
    Summary: Oral Hsp90β inhibitor, novel, fully synthetic
  2. MC1568
    A4094 MC1568
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: Class II HDAC inhibitor,potent and selective
      insoluble in EtOH; insoluble in H2O; ≥15.7 mg/mL
  3. XL-888
    A4388 XL-888
     1 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥18.2 mg/mL
  4. H-7 dihydrochloride
    B6342 H-7 dihydrochloride
    Target: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)
    Summary: protein kinase inhibitor
      Soluble in DMSO
  5. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  6. C646
    B1577 C646
     1 Citation
    Target: p300
    Summary: HAT p300-CBP inhibitor,cell-permeable
      insoluble in H2O; ≥11.14 mg/mL
  7. Dabrafenib Mesylate (GSK-2118436)
    A3347 Dabrafenib Mesylate (GSK-2118436)
    Target: Raf
    Summary: Inhibitor of BRAF(V600) mutants
      ≥30.75 mg/mL
  8. Lomeguatrib
    A1912 Lomeguatrib
    Target: O6-methylguanine-DNA-methyl-transferase (MGMT)
    Summary: MGMT inhibitor
      ≥50 mg/mL
  9. MS436
    B1012 MS436
    Target: Bromodomains
    Summary: BRD4 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.15 mg/mL
  10. GSK2636771
    B2186 GSK2636771
    Target: PI3K
    Summary: PIK3 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.83 mg/mL

Items 1-10 of 34

Page
per page